RAPID TREATMENT OF PERCODAN ADDICTION: A CASE REPORTGOLDSTEIN E; POLLACK R; WEINER B et al.1978; INTERNATION. J. ADDICT.; USA; DA. 1978; VOL. 13; NO 6; PP. 1003-1007; BIBL. 4 REF.Article

Experiencia con oxicodona en la rotación de opioide en el domicilio = Experience with oxycodone in opioid rotation at homeRAMOS POLLO, D; MARTIN GONZALEZ, M.Medicina paliativa. 2008, Vol 15, Num 1, pp 4-6, issn 1134-248X, 3 p.Article

OxycodoneKALSO, Eija.Journal of pain and symptom management. 2005, Vol 29, Num 5S, pp S47-S56, issn 0885-3924, SUPConference Paper

Controlled-release oxycodone for the management of pediatric postoperative painCZARNECKI, Michelle L; JANDRISEVITS, Matthew D; THEILER, Sarah C et al.Journal of pain and symptom management. 2004, Vol 27, Num 4, pp 379-386, issn 0885-3924, 8 p.Article

Marked variation in oxycodone pharmacokinetics in infantsPOKELA, Marja-Leena; ANTTILA, Eija; SEPPÄLÄ, Timo et al.Paediatric anaesthesia (Paris). 2005, Vol 15, Num 7, pp 560-565, issn 1155-5645, 6 p.Article

Opioid genetics: the key to personalized pain control?BRANFORD, R; DRONEY, J; ROSS, J. R et al.Clinical genetics. 2012, Vol 82, Num 4, pp 301-310, issn 0009-9163, 10 p.Article

Rotación opioide a oxicodona : éxito en un caso de dolor neuropático = Opioid rotation to oxycodone : a successfully treated case of neuropathic painSEGURA FERNANDEZ, E; MARTINEZ FERNANDEZ, C; GARCIA JUNQUERO, M. R et al.Medicina paliativa. 2006, Vol 13, Num 2, pp 59-60, issn 1134-248X, 2 p.Article

Oxycodone et douleur cancéreuse = Oxycodone and cancer painCAZABAN-MAZEROLLES, Joëlle.Medecine palliative. 2005, Vol 4, Num 2, pp 53-57, issn 1636-6522, 5 p.Article

Oxycodone alters temporal summation but not conditioned pain modulation: Preclinical findings and possible relations to mechanisms of opioid analgesiaSUZAN, Erica; MIDBARI, Ayelet; TREISTER, Roi et al.Pain (Amsterdam). 2013, Vol 154, Num 8, pp 1413-1418, issn 0304-3959, 6 p.Article

Pharmacokinetics of oxycodone after subcutaneous administration in a critically ill population compared with a healthy cohortKRISHNAMURTHY, R. B; UPTON, R. N; MACINTYRE, P. E et al.Anaesthesia and intensive care. 2012, Vol 40, Num 2, pp 269-274, issn 0310-057X, 6 p.Article

Economic Costs of Nonmedical Use of Prescription OpioidsHANSEN, Ryan N; OSTER, Gerry; EDELSBERG, John et al.The Clinical journal of pain. 2011, Vol 27, Num 3, pp 194-202, issn 0749-8047, 9 p.Article

Neuropathic Pain : The Case for Opioid TherapyALLEN, Stephen C.Oncology. 2008, Vol 74, pp 76-82, issn 0030-2414, 7 p., SUP1Conference Paper

Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic studySAARI, T. I; IHMSEN, H; NEUVONEN, P. J et al.British journal of anaesthesia. 2012, Vol 108, Num 3, pp 491-498, issn 0007-0912, 8 p.Article

Long-term use of controlled-release oxycodone for noncancer pain : Results of a 3-year registry study. CommentaryPORTENOY, Russell K; FARRAR, John T; KATZ, Nathaniel et al.The Clinical journal of pain. 2007, Vol 23, Num 4, pp 287-306, issn 0749-8047, 20 p.Article

Caractéristiques cliniques des douleurs cancéreuses sévères chez les patients traités par oxycodone. Cohorte OCS2 = Characteristics of background and breakthrough pain in cancer patient with severe pain treated with oxycodone. OCS2 cohortNAVEZ, Marie-Louise; CLERE, Florentin; KIROVA, Youlia et al.Douleurs (Paris). 2011, Vol 12, Num 3, pp 110-122, issn 1624-5687, 13 p.Article

Premedication with controlled-release oxycodone does not improve management of postoperative pain after day-case gynaecological laparoscopic surgeryJOKELA, R; AHONEN, J; VALJUS, M et al.British Journal of Anaesthesia. 2007, Vol 98, Num 2, pp 255-260, issn 0007-0912, 6 p.Article

10-HydroxythebainePROKSA, B.Archiv der Pharmazie (Weinheim). 1999, Vol 332, Num 10, pp 369-370, issn 0365-6233Article

Analgesic Efficacy of Peripheral κ-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model: Selective Effect on Visceral PainARENDT-NIELSEN, Lars; OLESEN, Anne E; STAAHL, Camilla et al.Anesthesiology (Philadelphia). 2009, Vol 111, Num 3, pp 616-624, issn 0003-3022, 9 p.Article

A comparison of the respiratory effects of oxycodone versus morphine: a randomised, double-blind, placebo-controlled investigationCHANG, S. H; MANEY, K. M; PHILLIPS, J. P et al.Anaesthesia. 2010, Vol 65, Num 10, pp 1007-1012, issn 0003-2409, 6 p.Article

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesiaZWISLER, S. T; ENGGAARD, T. P; MIKKELSEN, S et al.Acta anaesthesiologica scandinavica. 2010, Vol 54, Num 2, pp 232-240, issn 0001-5172, 9 p.Article

The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: A randomized, double-blind clinical trialCHANG, David J; DESJARDINS, Paul J; KING, Thomas R et al.Anesthesia and analgesia. 2004, Vol 99, Num 3, pp 807-815, issn 0003-2999, 9 p.Article

Plasma Concentrations of Oral Oxycodone Are Greatly Increased in the ElderlyLIUKAS, A; KUUSNIEMI, K; AANTAA, R et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 462-467, issn 0009-9236, 6 p.Article

Blood-Brain Barrier Transport Helps to Explain Discrepancies in In Vivo Potency between Oxycodone and MorphineBOSTRÖM, Emma; HAMMARLUND-UDENAES, Margareta; SIMONSSON, Ulrika S. H et al.Anesthesiology (Philadelphia). 2008, Vol 108, Num 3, pp 495-505, issn 0003-3022, 11 p.Article

CROSSOVER AND PARALLEL STUDY OF ORAL ANALGESICSWANG RIH; WAITE E.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 4; PP. 162-168; BIBL. 6 REF.Article

Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IRXU, Xu Steven; ETROPOLSKI, Mila; UPMALIS, David et al.Pharmaceutical research. 2012, Vol 29, Num 9, pp 2555-2564, issn 0724-8741, 10 p.Article